BeiGene on BTK Inhibitors and the Inflation Reduction Act.
- blonca9
- Jan 10, 2023
- 1 min read
Updated: Jun 17, 2023
John Oyler discusses BeiGene's BTK inhibitor Brukinsa and cautions about the Inflation Reduction Act.
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.